Receipt of HIV/STD prevention counseling by HIV-infected adults receiving medical care in the United States

Mizuno, Yuko; Zhu, Julia; Crepaz, Nicole; Beer, Linda; Purcell, David W.; Johnson, Christopher H.; Valverde, Eduardo E.; Skarbinski, Jacek

doi: 10.1097/QAD.0000000000000057
Epidemiology and Social

Objective: Guidelines recommend risk-reduction counseling by HIV providers to all HIV-infected persons. Among HIV-infected adults receiving medical care in the United States, we estimated prevalence of exposure to three types of HIV/sexually transmitted disease (STD) risk-reduction interventions and described the characteristics of persons who received these interventions.

Design: Data were from the Medical Monitoring Project (MMP), a supplemental HIV surveillance system designed to produce nationally representative estimates of behavioral and clinical characteristics of HIV-infected adults receiving medical care in the United States.

Methods: Descriptive analyses were conducted to estimate the exposure to each type of HIV/STD risk-reduction intervention. Bivariate and multivariable analyses were conducted to assess associations between the selected correlates with each exposure variable.

Results: About 44% of participants reported a one-on-one conversation with a healthcare provider about HIV/STD prevention, 30% with a prevention program worker, 16% reported participation in a small group risk-reduction intervention, and 52% reported receiving at least one of the three interventions in the past 12 months. Minority race/ethnicity, low income, and risky sexual behavior consistently predicted greater intervention exposure. However, 39% of persons who reported risky sex did not receive any HIV/STD risk-reduction interventions.

Conclusions: HIV-infected persons in care with fewer resources or those who engaged in risk behaviors were more likely to receive HIV/STD risk-reduction interventions. However, less than half of HIV-infected persons in care received HIV/STD prevention counseling from their provider, an intervention that has been shown to be effective and is supported by guidelines.

Division of HIV/AIDS Prevention, The U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Correspondence to Yuko Mizuno, PhD, Division of HIV/AIDS Prevention, The U.S. Centers for Disease Control and Prevention, 1600 Clifton Rd., Mailstop E-37, Atlanta, GA 30333, USA. Tel: +1 404 639 1925; fax: +1 404 639 1950; e-mail: ymizuno@cdc.gov

Received 19 July, 2013

Revised 21 August, 2013

Accepted 30 August, 2013

© 2014 Lippincott Williams & Wilkins, Inc.